英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
constrainte查看　constrainte　在百度字典中的解释百度英翻中〔查看〕
constrainte查看　constrainte　在Google字典中的解释Google英翻中〔查看〕
constrainte查看　constrainte　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • RINVOQ® (upadacitinib) for Ulcerative Colitis (UC)
    RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated It is not known if RINVOQ is safe and effective in children with ulcerative colitis
  • RINVOQ® (upadacitinib) Dosing for Ulcerative Colitis and Crohns Disease
    IMPORTANT SAFETY INFORMATION INDICATIONS 1 INDICATIONS 1 RINVOQ is indicated for the treatment of adults with: Moderately to severely active Crohn’s disease who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers ; Moderately to severely active ulcerative colitis who have had an inadequate response or intolerance to one or more TNF blockers
  • Rinvoq: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, giant cell arteritis, and polyarticular juvenile idiopathic arthritis Information includes Rinvoq side effects, interactions, and indications
  • Rinvoq: How It’s Used to Treat Ulcerative Colitis - Healthline
    Rinvoq (upadacitinib) is a prescription drug used to treat moderate to severe ulcerative colitis (UC) in adults It’s used when certain other treatments haven’t worked
  • Your Guide to Rinvoq for Ulcerative Colitis - HealthCentral
    Rinvoq is used to treat adults with moderate to severe ulcerative colitis when one or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not
  • Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A . . .
    Ulcerative colitis (UC) is a chronic immune-mediated disease of the colon The mainstay of treatment to achieve and maintain remission is 5-aminosalicylic acid (5-ASA) At least 20% of patients with UC experience an acute severe ulcerative colitis (ASUC) flare, requiring aggressive early intervention to prevent complications
  • Rinvoq (upadacitinib) for Ulcerative Colitis | IBD
    Rinvoq ® (upadacitinib) is approved to treat some adults with moderate or severe Crohn's disease or ulcerative colitis (UC) Before starting Rinvoq, users must have tried at least 1 tumor necrosis factor (TNF) blocker If it did not work or the user could not tolerate it, they can start using Rinvoq TNF blockers are a different type of drug
  • Rinvoq (upadacitinib) for Ulcerative Colitis - MPR
    Clinical Trials: Ulcerative Colitis In UC-3 , a greater proportion of patients treated with Rinvoq 15mg or 30mg achieved clinical remission at week 52 compared with placebo ( P < 001)
  • for Ulcerative Colitis - RINVOQ
    The efficacy and safety of RINVOQ ® in moderately to severely active ulcerative colitis patients were evaluated in three multicentre, double-blind, placebo-controlled Phase 3 clinical studies consisting of two replicate induction studies involving 988 patients (UC1 and UC2) and a maintenance study involving 451 patients (UC3) 1,4 Collectively, these trials supported that, compared to placebo
  • RINVOQ® (upadacitinib) Efficacy for Ulcerative Colitis
    Limitations of Use: RINVOQ is not recommended for use in combination with other JAK inhibitors, biological therapies for ulcerative colitis or Crohn’s disease, or with potent immunosuppressants such as azathioprine and cyclosporine RINVOQ RINVOQ LQ is indicated for the treatment of:





中文字典-英文字典  2005-2009